Miltefosine inhibits PI3K/Akt activity with ED50 of 17.2 µM and 8.1 µM in carcinoma cell lines A431 and HeLa, first oral compound for Visceral leishmaniasis, effective against both promastigotes and amastigotes.
Molecular Weight:
407.57
Purity:
>98.0%
CAS Number:
[58066-85-6]
Formula:
C21H46NO4P
Target:
Akt
* VAT and and shipping costs not included. Errors and price changes excepted